from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1324/-

LFCtreatmentdescriptionclass of inhibitor

-1.809

Amikacinug/mL Amikacintranslation

0.289

Cap5-10ug/mL Capreomycintranslation

-1.612

Rox10-50 ug/mL Roxithromycintranslation

1.165

SM2-5 ug/mL Streptomycintranslation

-2.252

Tet5-10 ug/mL Tetracyclinetranslation

-1.146

Rif0.2-5ug/mL Rifampicintranscription

-1.427

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.885

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.095

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.540

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.045

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.469

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.713

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.355

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.693

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.637

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.881

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.403

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.822

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.262

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.469

KCN5-20 ug/mL Potassium cyaniderespiration

0.537

NaN30.2-2 mM Sodium aziderespiration

-0.449

Nigericin50 uM Nigericinrespiration

-0.861

TRC10-150 ug/mL Triclosanrespiration

-0.799

TRZ10-25 ug/mL Thioridazinerespiration

-0.561

Valinomycin0.5-10 uM Valinomycinrespiration

0.296

ZnSO42 mM ZnSO4respiration

-0.499

menadione6-10 ug/mL Menadionerespiration

-0.353

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.484

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.206

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.043

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.093

NRP_1Non-replicating persistence stage 1dosRassociated

0.895

Amp0.2mg/mL AmpicillincellWall

-0.454

Cephalexin20-100 ug/mL CephalexincellWall

0.637

Cerulenin0.32-5 ug/mL CerulenincellWall

0.784

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.503

EMB10-20 ug/mL EthambutolcellWall

0.859

Eta12-40 ug/mL EthionamidecellWall

1.136

INH0.2-0.4 ug/mL IsoniazidcellWall

0.491

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.517

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.983

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.019

BZA0.12 mg/mL BenzamidearomaticAmides

0.495

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.252

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.295

H2O24 mM hydrogen peroxideDNAdamaging

-0.390

Levo10 ug/mL LevofloxacinDNAdamaging

1.205

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.806

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.109

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.316

UVUV-irradiationDNAdamaging

-0.633

ARP41-4 ug/mL Antitubercular compound ARP4?

0.151

Antimycin12.5-50 ug/mL Antimycin A?

-0.466

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.092

PA_110-50 ug/mL Antitubercular compound PA-1?

0.110

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.208

PA8240.2-2 ug/mL PA-824?

1.753

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.984

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.808

Verapamil50 uM Verapamil?

-0.470

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.716

methoxatin10-20 ug/mL Methoxatin?